Cumberland Pharmaceuticals (NASDAQ:CPIX) Now Covered by Analysts at began coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIXGet Rating) in a report released on Monday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock.

Cumberland Pharmaceuticals Stock Performance

Shares of CPIX opened at $2.30 on Monday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.94 and a quick ratio of 1.52. Cumberland Pharmaceuticals has a one year low of $1.89 and a one year high of $7.51. The firm has a market capitalization of $33.72 million, a P/E ratio of -4.89 and a beta of 0.28. The business has a fifty day moving average of $2.41 and a 200 day moving average of $2.29.

Institutional Trading of Cumberland Pharmaceuticals

Large investors have recently modified their holdings of the company. Renaissance Technologies LLC grew its holdings in shares of Cumberland Pharmaceuticals by 6.3% in the first quarter. Renaissance Technologies LLC now owns 644,763 shares of the specialty pharmaceutical company’s stock worth $1,818,000 after acquiring an additional 38,100 shares during the period. Acadian Asset Management LLC grew its holdings in Cumberland Pharmaceuticals by 27.8% during the first quarter. Acadian Asset Management LLC now owns 188,243 shares of the specialty pharmaceutical company’s stock valued at $529,000 after purchasing an additional 40,949 shares during the period. Finally, M Holdings Securities Inc. bought a new stake in Cumberland Pharmaceuticals during the first quarter valued at about $30,000. Institutional investors own 18.48% of the company’s stock.

About Cumberland Pharmaceuticals

(Get Rating)

Cumberland Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.

Further Reading

Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with's FREE daily email newsletter.